Voyager Therapeutics Inc. (VYGR)
NASDAQ: VYGR
· Real-Time Price · USD
3.12
-0.03 (-0.95%)
At close: May 22, 2025, 9:53 AM
Voyager Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2017 |
|---|---|
| Parkinsonprogram Revenue | 5.5M |
| Parkinsonprogram Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.64M | 8.99M | 8.17M | 10.15M | 8.61M | 10.24M | 8.26M | 8.29M | 9.03M | 8.46M | 7.31M | 7.55M | 7.66M | 8.35M | 8.71M | 10.44M | 9.74M | 8.27M | 8.28M | 8.24M | 10.21M | 9.89M | 8.46M | 8.32M | 9.66M | 8.26M | 6.61M | 11.76M | 7.18M | 5.37M | 4.94M | 4.52M | 4.91M | 3.48M | 3.37M | 2.85M | 3.56M | 3.16M | 2.48M | 2.4M | 1.88M |
| Selling, General, and Administrative Revenue Growth | +7.18% | +10.11% | -19.54% | +17.94% | -15.96% | +24.03% | -0.43% | -8.13% | +6.69% | +15.81% | -3.24% | -1.40% | -8.29% | -4.17% | -16.51% | +7.11% | +17.82% | -0.08% | +0.46% | -19.27% | +3.18% | +16.87% | +1.69% | -13.84% | +17.01% | +24.91% | -43.81% | +63.77% | +33.84% | +8.58% | +9.43% | -8.10% | +41.17% | +3.29% | +18.08% | -19.94% | +12.92% | +27.56% | +3.30% | +27.38% | n/a |
| Research and Development Revenue | 31.53M | 35.58M | 30.24M | 34.45M | 25.9M | 24.42M | 25.86M | 21.98M | 18.57M | 14.55M | 19.34M | 12.53M | 14.35M | 14.02M | 17.91M | 19.5M | 22.35M | 22M | 25.04M | 29.42M | 32.29M | 36.55M | 29.78M | 28.58M | 24.83M | 16.91M | 16.63M | 16.51M | 14.85M | 13.33M | 19.56M | 15.3M | 14.07M | 12.72M | 10.31M | 10.48M | 8.73M | 9.22M | 6.48M | 6.46M | 5.52M |
| Research and Development Revenue Growth | -11.40% | +17.66% | -12.22% | +33.04% | +6.04% | -5.58% | +17.64% | +18.40% | +27.61% | -24.75% | +54.36% | -12.70% | +2.35% | -21.74% | -8.16% | -12.71% | +1.59% | -12.15% | -14.90% | -8.89% | -11.65% | +22.75% | +4.20% | +15.08% | +46.81% | +1.70% | +0.76% | +11.14% | +11.45% | -31.87% | +27.85% | +8.73% | +10.60% | +23.42% | -1.67% | +20.06% | -5.29% | +42.26% | +0.40% | +16.87% | n/a |